부산대학교 도서관

Heymann, S. ; Verstraet, R. ; Pichenot, C. ; Vergne, E. ; Lefkopoulos, D. ; Husson, F. ; Kafrouni, H. ; Mahe, J. ; Kandalaft, B. ; Bourhis, J. ; Marsiglia, H. ; Bourgier, C.

In Cancer / Radiothérapie 2011 15(8):663-669

Kandalaft, Firas; Bouhous, Nouredine; Houque, Didier; Coppe-Scotte, Caroline; Verlet, Erick; Chachoua, Karim; Tricot, Olivier; Rousselle, Anne Flore

Diabetes and Metabolism. 43(2):A52-A53

In Motricité cérébrale July-September 2021 42(3):90-93

Tzeng SF; Tumor Immune Analysis Core, Office of Research & Development, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.; Yu YR; Pilatus Biosciences SA, Epalinges, Switzerland.; Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.; Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.; Park J; Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.; Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.; von Renesse J; Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.; Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.; Hsiao HW; Elixiron Immunotherapeutics Inc., Taipei, Taiwan.; Hsu CH; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.; Garnica J; Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.; Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Chen J; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Chiu LT; Pilatus Biosciences SA, Epalinges, Switzerland.; Santol J; Department of Surgery, HPB Center, Vienna Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.; Institute of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.; Chen TY; Department of Medical Imaging and Radiological Sciences, Cancer Genome Research Center, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.; Department of Radiation Oncology, Cancer Genome Research Center, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.; Chung PH; Elixiron Immunotherapeutics Inc., Taipei, Taiwan.; Kandalaft LE; Department of Oncology, University of Lausanne, CHUV, Lausanne, Switzerland.; Starlinger P; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.; Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.; Hsieh RC; Department of Medical Imaging and Radiological Sciences, Cancer Genome Research Center, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.; Department of Radiation Oncology, Cancer Genome Research Center, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.; Yu MC; Department of surgery, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, Taiwan.; Hsiao PW; Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.; Carmona SJ; Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.; Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Chen HK; Elixiron Immunotherapeutics Inc., Taipei, Taiwan.; Meng Z; Society of Toxicology, Reston, Virginia.; Lin YH; Pilatus Biosciences SA, Epalinges, Switzerland.; Zhou J; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Tsai CH; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.; International Ph.D./Master Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ho PC; Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.; Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Sara Bobisse; Raphael Genolet; Annalisa Roberti; Janos L. Tanyi; Julien Racle; Brian J. Stevenson; Christian Iseli; Alexandra Michel; Marie-Aude Le Bitoux; Philippe Guillaume; Julien Schmidt; Valentina Bianchi; Denarda Dangaj; Craig Fenwick; Laurent Derré; Ioannis Xenarios; Olivier Michielin; Pedro Romero; Dimitri S. Monos; Vincent Zoete; David Gfeller; Lana E. Kandalaft; George Coukos; Alexandre Harari

Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)

Banerjee, S.; Ghisoni, E.; Szturz, P.; Coukos, G.; Morotti, M.; Kandalaft, L.; Herrera, F.; Laniti, D.D.; Wolfer, A.; Ottevanger, P.B.; Le Scodan, R.; Sarivalasis, A.; Montes, A.; Kroep, J.; Marin, M.R.; Dagher, J.; Coens, C.

In: Clinical Cancer Research. (Clinical Cancer Research, 1 June 2025, 31(11):2145-2153)

Ferreira HJ; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Stevenson BJ; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland.; Pak H; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Yu F; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.; Almeida Oliveira J; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Huber F; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Taillandier-Coindard M; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Michaux J; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Ricart-Altimiras E; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Kraemer AI; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Kandalaft LE; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Speiser DE; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Nesvizhskii AI; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Müller M; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland.; Bassani-Sternberg M; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. michal.bassani@chuv.ch.; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. michal.bassani@chuv.ch.; Agora Cancer Research Centre, Lausanne, Switzerland. michal.bassani@chuv.ch.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. michal.bassani@chuv.ch.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Ghisoni E; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Orcurto A; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Dagher J; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.; Fahr N; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Morotti M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Zimmermann S; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Duran R; Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.; Imbimbo M; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; de Olza MO; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Navarro B; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Homicsko K; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Labes D; Flow Cytometry Facility, Department of Formation and Research, University of Lausanne, Epalinges, Switzerland.; Tsourti Z; Scientific Research Consulting Hellas, Athens, Greece.; Andriakopoulou C; Scientific Research Consulting Hellas, Athens, Greece.; Herrera F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Service of Radiation Oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Berthod G; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Kraemer AI; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Huber F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Thevenet J; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Schaefer N; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.; Prior JO; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.; Matter M; Department of Visceral Surgery, Lausanne University Hospital, and University of Lausanne, Lausannne, Switzerland.; Aedo V; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Dromain C; Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.; Corria-Osorio J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Tissot S; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Gottardo R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Biomedical Data Science Center and Swiss Institute of Bioinformatics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.; Pittet M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Sempoux C; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.; Michielin O; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Dafni U; Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece.; Trueb L; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Laniti DD; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Perez MAS; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Schmidt J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Lozano-Rabella M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Sauvage C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Saugy D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Michel A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Huguenin-Bergenat AL; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Capt C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Moore JS; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; De Vito C; Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Labidi-Galy SI; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Oliveira G; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wu CJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Zoete V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch.

Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Perez MAS; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Schmidt J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Lozano-Rabella M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Sauvage C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Saugy D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Michel A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Huguenin-Bergenat AL; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Capt C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Moore JS; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; De Vito C; Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Labidi-Galy SI; Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Oliveira G; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wu CJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Zoete V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch.

Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE; PubMed not MEDLINE

Audet, J.; Bélanger, A.; Beaudet, G.; Brazeau, A.; Caponi, É.; Caron, D.; Dubé, A.; Kandalaft, N.; Lelièvre, M.; Lemonnier, M.-C.; Mailhot, J.; Ménard, D.; Monier, D.

Patient Education and Counseling. 23:S129-S129

Zsiros E; Duttagupta P; Dangaj D; Li H; Frank R; Garrabrant T; Hagemann IS; Levine BL; June CH; Zhang L; Wang E; Marincola FM; Bedognetti D; Powell DJ Jr; Tanyi J; Feldman MD; Kandalaft LE; Coukos G

Clinical Cancer Research, vol. 21, no. 12, pp. 2840-2850

Mastelic-Gavillet B; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Sarivalasis A; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Lozano LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Lofek S; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Wyss T; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Bioinformatics Core Facility, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.; Instituto de Investigacion Sanitaria de Navarra, Pamplona, Spain.; Departments of Immunology-Immunotherapy and Oncology, University Clinic, University of Navarra, Pamplona, Spain.; Program of Immunology and Immunotherapy, Centro de Investigacion Biomedica en Red Cancer, Madrid, Spain.; de Vries IJM; Department of Tumour Immunology, Radboud Institute of Molecular Life Sciences, Nijmegen, Netherlands.; Harari A; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Romero P; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Kandalaft LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Viganó S; Department of Oncology, Centre Hospitalier Universitaire Vaudois and Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

George Coukos; Denarda Dangaj Laniti; Corneel Coens; Fernanda Herrera; Lana Kandalaft; Julien Dagher; Matteo Morotti; Petr Szturz; Margarita Romeo Marin; Judith Kroep; Ana Montes; Apostolos Sarivalasis; Romuald Le Scodan; Petronella Beatrix Ottevanger; Anita Wolfer; Eleonora Ghisoni; Susana Banerjee

George Coukos; Denarda Dangaj Laniti; Corneel Coens; Fernanda Herrera; Lana Kandalaft; Julien Dagher; Matteo Morotti; Petr Szturz; Margarita Romeo Marin; Judith Kroep; Ana Montes; Apostolos Sarivalasis; Romuald Le Scodan; Petronella Beatrix Ottevanger; Anita Wolfer; Eleonora Ghisoni; Susana Banerjee

George Coukos; Denarda Dangaj Laniti; Corneel Coens; Fernanda Herrera; Lana Kandalaft; Julien Dagher; Matteo Morotti; Petr Szturz; Margarita Romeo Marin; Judith Kroep; Ana Montes; Apostolos Sarivalasis; Romuald Le Scodan; Petronella Beatrix Ottevanger; Anita Wolfer; Eleonora Ghisoni; Susana Banerjee

Schmidt J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Chiffelle J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Perez MAS; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Magnin M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Bobisse S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Arnaud M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Genolet R; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Cesbron J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Barras D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Navarro Rodrigo B; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Benedetti F; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Michel A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Queiroz L; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Baumgaertner P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Guillaume P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Hebeisen M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Nguyen-Ngoc T; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Huber F; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Irving M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Tissot-Renaud S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Stevenson BJ; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Rusakiewicz S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Rufer N; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Gfeller D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Speiser DE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Zoete V; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Coukos G; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Harari A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. Alexandre.Harari@chuv.ch.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. Alexandre.Harari@chuv.ch.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

George Coukos; Denarda Dangaj Laniti; Corneel Coens; Fernanda Herrera; Lana Kandalaft; Julien Dagher; Matteo Morotti; Petr Szturz; Margarita Romeo Marin; Judith Kroep; Ana Montes; Apostolos Sarivalasis; Romuald Le Scodan; Petronella Beatrix Ottevanger; Anita Wolfer; Eleonora Ghisoni; Susana Banerjee

Graciotti M; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland. lkandalaft@lcr.org.; Department of Oncology, University of Lausanne (UNIL), Lausanne, Switzerland. lkandalaft@lcr.org.; AGORA Cancer Research Center, Lausanne, Lausanne, Switzerland. lkandalaft@lcr.org.; Swiss Medical Network, Genolier Innovation Network, Genolier Clinic, Genolier, Switzerland. lkandalaft@lcr.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE

Martinez Bedoya D; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Marinari E; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Davanture S; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Castillo Cantero L; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Erraiss S; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Dockerill M; Department of Organic Chemistry, NCCR Chemical Biology, Faculty of Science, University of Geneva, Geneva, Switzerland.; Barluenga S; Department of Organic Chemistry, NCCR Chemical Biology, Faculty of Science, University of Geneva, Geneva, Switzerland.; Winssinger N; Department of Organic Chemistry, NCCR Chemical Biology, Faculty of Science, University of Geneva, Geneva, Switzerland.; Schaller K; Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospital, Geneva, Switzerland.; Bijlenga P; Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospital, Geneva, Switzerland.; Momjian S; Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospital, Geneva, Switzerland.; Voize C; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Tissot SR; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Kandalaft LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Hammel P; Geneva Antibody Facility, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Cosson P; Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Walker PR; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Dutoit V; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Migliorini D; Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE